BRAINTREE, Mass., April 7, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will report its results for the fourth quarter and fiscal year 2016 on Monday, May 2, 2016 in a pre-market press release. As previously announced, the Company will provide its outlook for fiscal 2017 as part of a comprehensive review of its business franchise strategies at its annual investor day event on May 10, 2016.
The Company will hold a webcast conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on May 2, 2016.
Webcast Link: http://edge.media-server.com/m/p/jt7cd6n7.
Webcast replay will be available from May 2, 2016 after 11:00am Eastern Time until May 31, 2016.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at www.haemonetics.com.
Gerry Gould, VP-Investor Relations
Sandra Jesse, Executive VP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-4th-quarter-and-fiscal-2016-earnings-release-may-2-2016-300247948.html
SOURCE Haemonetics Corporation